Harmony Biosciences Holdings Inc (NAS:HRMY)
$ 34.2 -0.52 (-1.5%) Market Cap: 1.95 Bil Enterprise Value: 1.75 Bil PE Ratio: 16.21 PB Ratio: 3.27 GF Score: 65/100

Harmony Biosciences Holdings Inc at Needham Neuroscience Forum (Virtual) Transcript

Mar 16, 2022 / 12:45PM GMT
Release Date Price: $47.72 (+8.90%)
Ami Fadia
Needham & Company, LLC, Research Division - Research Analyst

Good morning, everyone, again. Welcome to the second session with Harmony Bioscience. It's my pleasure to have Jeff Dayno, who's the Chief Medical Officer of Harmony. He has significant experience in leadership roles in multiple companies as well as clinical and academic medicine as a principal investigator. We are lucky to have him today in the session. Jeff, thank you so much.

Perhaps if we could maybe just kick off with some questions, if that's okay with you.

Jeffrey M. Dayno
Harmony Biosciences Holdings, Inc. - Chief Medical Officer

Yes, that sounds great, Ami. So Good morning. It's a pleasure to be here with you this morning. And on behalf of the whole team at Harmony, thank you very much for the invitation and opportunity to participate in Needham's first annual Neuroscience forum. It's great to be here.

Questions & Answers

Ami Fadia
Needham & Company, LLC, Research Division - Research Analyst

Okay. Great.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot